fda changes semaglutide 🚨 Ends Shortage The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Semaglutide FDA Approval vs Compounded

Weight regain after discontinuation is common, with studies showing 60-70% of lost weight returning within a year of stopping

Adjusting the dosage schedule, recommending dietary changes, or temporarily pausing treatment are all strategies providers may use to improve tolerability

Regular exercise: Aerobic and strength training exercise can both support improved natural GLP-1 signaling

Looking for an energy boost

Benefits Selective activation of melanocortin-1 receptors: Melanotan I has been studied for its selective activation of MC1R receptors located on melanocytes

Peaks were called using MACS2 (v2.2.6) with the parameters -q 0.05 --nomodel --nolambda